Peyronie Disease

• FDA approval · 2024-10-11
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) submitted by Endo USA, Inc., to modify/expand…

• FDA approval · 2023-07-12
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc.

• FDA approval · 2022-06-09
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) submitted by Endo USA, Inc., representing an …

• FDA approval · 2021-04-13
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  FDA approved a supplemental application for Xiaflex (collagenase clostridium histolyticum) submitted by Endo USA, Inc. The approval expands …

• FDA approval · 2018-06-06
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) filed by Endo USA, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-11-28
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc., marking an approved update t…

• FDA approval · 2016-09-19
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) from Endo USA, Inc., indicating an approval relat…

• FDA approval · 2012-02-24
  FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

  The FDA approved a supplemental application for XIAFLEX (collagenase clostridium histolyticum) by Endo USA, Inc., marking an update to the p…